Phase III efficacy data on bevacizumab plus chemotherapy in early breast cancer to be presented
Friday, December 10, 2010 - 19:30
in Health & Medicine
Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.